Skip to content

Ankle Inversion control effects of Lateral Wedge Insole Versus Semirigid Ankle Orthosis on an Unsteady Surface : Crossover Randomized Control Trial (Crossover RCT)

Ankle Inversion control effects of Lateral Wedge Insole Versus Semirigid Ankle Orthosis on an Unsteady Surface : Crossover Randomized Control Trial (Crossover RCT)

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260718005
Enrollment
22
Registered
2026-07-18
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle sprain Ankle Inversion control effect Lateral wedge insole Semirigid ankle orthosis Ankle inversion control Ankle sprain Ankle kinetic parameter Unsteady surface subtalar joint varus angle subtalar joint varus moment

Interventions

custom-made lateral wedge insole Incline 6 degree Height 0.5 cm Material EVA Foam size 22, 22.5, 23, 23.5, 24, 24.5, 25, 25. 5, 26, 26.5, 27 cm,Semirigid Ankle Orthosis (SAO) Ankle Support Size S, M,
Experimental Device,Experimental Device
Lateral Wedge Insole,Semirigid Ankle Orthosis

Sponsors

Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-50 years old 2. Normal ankle morphology and full range of motion 3. Normal walking ability 4. Consent to study

Exclusion criteria

Exclusion criteria: 1. Any active ankle pathology 2. Any musculoskeletal or neurological impairment which affects ankle movement and walking ability 3. History of ankle surgery

Design outcomes

Primary

MeasureTime frame
Kinematic Ankle Parameter (Subtalar joint varus angle) simultaneously degree

Secondary

MeasureTime frame
Kinetic Ankle Parameter (Subtalar joint moment) simultaneously Newton-meter (Nm)

Countries

Thailand

Contacts

Public ContactSirawit Aroonratana

Department of Rehabilitation Medicine, Faculty of Medicine, Chulalongkorn University

sirawit.aroonratana@gmail.com0941651514

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026